Atara Biotherapeutics (ATRA) FCF Margin (2021 - 2026)
Atara Biotherapeutics (ATRA) posted FCF Margin of -529.84% for Q2 2026, down 488.20 percentage points from -41.64% a year earlier but up 65.70 percentage points from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) FCF Margin (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, FCF Margin at Atara Biotherapeutics was -353.49%, down 319.56 percentage points year-over-year; for FY2025, it was -42.18%, up 11.31 percentage points from FY2024.
- Annual FCF Margin shows a four-year change of +1094.02 percentage points (FY2021 to FY2025).
- In prior years, Atara Biotherapeutics' FCF Margin was -53.48% in FY2024 (+2211.77 pp), -2265.25% in FY2023 (-1833.45 pp), -431.80% in FY2022 (+704.40 pp) and -1136.19% in FY2021.
- Quarterly FCF Margin has run from a low of -22950.40% in Q4 2022 to a high of -9.93% in Q3 2024 over five years.
- On a year-over-year basis, FCF Margin has declined in each of the last five quarters, with an average year-over-year change of +247.65 percentage points over the last eight quarters.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q4 2023, with a gain of 21763.90 percentage points; the weakest was Q4 2022, with a drop of 22463.72 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was -595.54% (Q1 2026), -357.18% (Q4 2025) and -283.43% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 30.39% |
| 10 | Atara Biotherapeutics | 127.78 Mn | 117.88 Mn | 439,000.00 | -529.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -529.84% |
| Mar 31, 2026 | -595.54% |
| Dec 31, 2025 | -357.18% |
| Sep 30, 2025 | -283.43% |
| Jun 30, 2025 | -41.64% |
| Mar 31, 2025 | -28.67% |
| Dec 31, 2024 | -74.99% |
| Sep 30, 2024 | -9.93% |
| Jun 30, 2024 | -37.27% |
| Mar 31, 2024 | -108.71% |
| Dec 31, 2023 | -1,186.50% |
| Sep 30, 2023 | -2,414.73% |
| Jun 30, 2023 | -5,568.97% |
| Mar 31, 2023 | -3,167.05% |
| Dec 31, 2022 | -22,950.40% |
| Sep 30, 2022 | -1,461.96% |
| Jun 30, 2022 | -126.76% |
| Mar 31, 2022 | -1,191.33% |
| Dec 31, 2021 | -486.69% |
| Sep 30, 2021 | -1,170.09% |
API Access
Atara Biotherapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();